Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Two patients with porphyria cutanea tarda experienced their grey hair turning dark again.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

Saw palmetto causes allergic reaction, minoxidil causes skin irritation; use cautiously for hair loss.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Hair changes can indicate systemic diseases or medication effects.

Hair graying is influenced by factors like nerves, fat cells, and immune cells, not just hair follicles.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

Using bacitracin zinc and selenium sulfide one after the other can temporarily turn white hair yellow.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

Hydroxychloroquine effectively treated twenty-nail dystrophy in a patient with alopecia areata.

Heptaminol may cause hair lightening in hemodialysis patients.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

SLE patients need careful diagnosis to distinguish infections from disease flares for proper treatment.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Clofazimine effectively treated a rare skin condition with ash-gray patches.

Premature graying of hair is common and stressful, but not well understood or treated.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

A new diagnostic tool for Vulvovaginal Lichen Planus is highly accurate, and updated treatments for various skin conditions, including melanoma and Hidradenitis Suppurativa, were discussed.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Watching, not removing, skin growths with moderate atypia and positive edges is okay; patients may get melanoma elsewhere, especially if they've had it before.

Hydroxychloroquine may cause false results in tuberculosis tests for patients with autoimmune skin diseases.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.